FDA authorizes Pfizer Covid booster dose for kids ages 5 to 11 years old
The Food and Drug Administration on Tuesday authorized a Pfizer booster dose for children ages 5 through 11 years old at least five months after they complete their two-dose primary series.
Dr. Peter Marks, head of the FDA division responsible for vaccines, said data increasingly shows that the protection provided by two shots wanes off over time. The FDA determined that a third shot can help boost protection for children in this age group and the benefits outweigh the risks, Marks said.
The FDA decided to authorize a third shot...